Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain
- PMID: 17530038
Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain
Abstract
High usage of antibiotics in Spain has led to an increase in resistance in urinary Escherichia coli isolates in different geographic regions. The problem of resistance in urinary E. coli in Spain was investigated by gathering a large number of isolates from 20 different sites nationwide over a 1-year period from November 2003 to October 2004 in a large population of women. The objectives of this study were to assess the resistance to the antibiotics most commonly prescribed for community-acquired urinary tract infections (UTIs), according to age and different geographical areas of Spain, and to evaluate the potential association between geographical differences in quinolone consumption and resistance to E. coli. A total of 2,292 valid E. coli strains from female outpatients were isolated and sent to a single central reference laboratory for confirmation and susceptibility testing. Of these, 2,230 isolates were available for the age analysis. A two-sided chi2 test was used to identify differences in resistance between age groups. Antibiotic units per province were purchased from IMS and consumption was expressed in units per 1,000 people per year. Univariate correlation (Pearson coefficient) between resistance to ciprofloxacin and quinolone consumption was calculated using a two-sided p-value. Resistance shown by E. coli was more common to ampicillin (52.1%) and cotrimoxazole (26%), followed by quinolones (18%), whereas resistance to amoxicillin-clavulanic acid, cefuroxime-axetil and fosfomycin was less than 3%. In the subgroup of women aged >65 years, resistance to ciprofloxacin was 29% compared to 13% for the subgroup of women <65 years (p<0.001). For these same subgroups, resistance rates were 32% vs. 23% for cotrimoxazole (p<0.001) and 56% vs. 50% for ampicillin (p=0.02), respectively. Statistically significant correlations were found between consumption of quinolones and E. coli resistance to ciprofloxacin (r=0.5; p=0.025). Resistance of E. coli isolates to quinolones varied significantly according to geographical areas, ranging from a high of 16.5% and 16.6% in the southern and eastern regions of Spain, respectively, to a low of 8% in the north in women aged <65 years. Additionally, the susceptibility to quinolones of E. coli isolates recovered from women aged >65 years was significantly lower across all regions of Spain than that of isolates recovered from younger women. Fosfomycin, amoxicillin/clavulanic acid and cefuroxime-axetil are the most suitable antibiotics for empirical treatment in Spain given the high 18% and 26% resistance rates to quinolones and cotrimoxazole, respectively. Higher resistance rates to ciprofloxacin were associated with being aged 65 years and over. These data need to be considered when recommending empirical therapy for acute cystitis.
Similar articles
-
Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.Rev Esp Quimioter. 2007 Jun;20(2):206-10. Rev Esp Quimioter. 2007. PMID: 17893757
-
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.J Antimicrob Chemother. 2005 Nov;56(5):914-8. doi: 10.1093/jac/dki344. Epub 2005 Sep 20. J Antimicrob Chemother. 2005. PMID: 16174685
-
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.Int J Antimicrob Agents. 2012 Jan;39(1):45-51. doi: 10.1016/j.ijantimicag.2011.09.013. Epub 2011 Nov 3. Int J Antimicrob Agents. 2012. PMID: 22055529
-
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.Dan Med Bull. 2011 Apr;58(4):B4187. Dan Med Bull. 2011. PMID: 21466767 Review.
-
Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S54-66. doi: 10.1016/j.ijantimicag.2003.12.005. Int J Antimicrob Agents. 2004. PMID: 15037329 Review.
Cited by
-
Compliance to international guidelines and rational use of antibiotics in urinary tract infections in a country without national guidance: a cross-sectional study.BMJ Open Qual. 2024 Dec 23;13(4):e003027. doi: 10.1136/bmjoq-2024-003027. BMJ Open Qual. 2024. PMID: 39719274 Free PMC article.
-
Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001-2015.BJGP Open. 2017 Oct 4;1(4):bjgpopen17X101145. doi: 10.3399/bjgpopen17X101145. eCollection 2018 Jan. BJGP Open. 2017. PMID: 30564685 Free PMC article.
-
Fosfomycin: Resurgence of an old companion.J Infect Chemother. 2016 May;22(5):273-80. doi: 10.1016/j.jiac.2016.01.010. Epub 2016 Feb 28. J Infect Chemother. 2016. PMID: 26923259 Free PMC article. Review.
-
Fosfomycin: an old, new friend?Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):127-42. doi: 10.1007/s10096-009-0833-2. Epub 2009 Nov 14. Eur J Clin Microbiol Infect Dis. 2010. PMID: 19915879 Review.
-
Fluoroquinolone resistance determinants in carbapenem-resistant Escherichia coli isolated from urine clinical samples in Thailand.PeerJ. 2023 Nov 8;11:e16401. doi: 10.7717/peerj.16401. eCollection 2023. PeerJ. 2023. PMID: 37953793 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical